{"authors": [["Pennini", "Meghan E", "ME", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA."], ["De Marco", "Anna", "A", "Humabs BioMed SA, a subsidiary of Vir Biotechnology, Inc., Via Mirasole 1, 6500, Bellinzona, Switzerland."], ["Pelletier", "Mark", "M", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA."], ["Bonnell", "Jessica", "J", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA."], ["Cvitkovic", "Romana", "R", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA."], ["Beltramello", "Martina", "M", "Humabs BioMed SA, a subsidiary of Vir Biotechnology, Inc., Via Mirasole 1, 6500, Bellinzona, Switzerland."], ["Cameroni", "Elisabetta", "E", "Humabs BioMed SA, a subsidiary of Vir Biotechnology, Inc., Via Mirasole 1, 6500, Bellinzona, Switzerland."], ["Bianchi", "Siro", "S", "Humabs BioMed SA, a subsidiary of Vir Biotechnology, Inc., Via Mirasole 1, 6500, Bellinzona, Switzerland."], ["Zatta", "Fabrizia", "F", "Humabs BioMed SA, a subsidiary of Vir Biotechnology, Inc., Via Mirasole 1, 6500, Bellinzona, Switzerland."], ["Zhao", "Wei", "W", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA."], ["Xiao", "Xiaodong", "X", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA."], ["Camara", "Maria M", "MM", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA."], ["DiGiandomenico", "Antonio", "A", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA."], ["Semenova", "Elena", "E", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA."], ["Lanzavecchia", "Antonio", "A", "Institute for Research in Biomedicine, Universit\u00e0 della Svizzera Italliana, Via Vincenzo Vela 6, 6500, Bellinzona, Switzerland."], ["Warrener", "Paul", "P", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA."], ["Suzich", "JoAnn", "J", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA."], ["Wang", "Qun", "Q", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA. qunwang2001@hotmail.com."], ["Corti", "Davide", "D", "Humabs BioMed SA, a subsidiary of Vir Biotechnology, Inc., Via Mirasole 1, 6500, Bellinzona, Switzerland. davide.corti@humabs.ch."], ["Stover", "C Kendall", "CK", "MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA. stoverk@medimmune.com."]], "date": "2017-12-08", "id": "29222409", "text": "Emerging multidrug-resistant bacteria are a challenge for modern medicine, but how these pathogens are so successful is not fully understood. Robust antibacterial vaccines have prevented and reduced resistance suggesting a pivotal role for immunity in deterring antibiotic resistance. Here, we show the increased prevalence of Klebsiella pneumoniae lipopolysaccharide O2 serotype strains in all major drug resistance groups correlating with a paucity of anti-O2 antibodies in human B cell repertoires. We identify human monoclonal antibodies to O-antigens that are highly protective in mouse models of infection, even against heavily encapsulated strains. These antibodies, including a rare anti-O2 specific antibody, synergistically protect against drug-resistant strains in adjunctive therapy with meropenem, a standard-of-care antibiotic, confirming the importance of immune assistance in antibiotic therapy. These findings support an antibody-based immunotherapeutic strategy even for highly resistant K. pneumoniae infections, and underscore the effect humoral immunity has on evolving drug resistance.", "doi": "10.1038/s41467-017-02223-7", "title": "Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae.", "journal": ["Nature communications", "Nat Commun"]}